glp-1 law suit ad war leads to lawsuit by Novo Nordisk, claiming Eli Lilly misleads Can I Join a NAION

One followed roughly 9,000 participants with Type 2 diabetes and cardiovascular risk: those taking the GLP-1 dulaglutide had a 14% reduction in the risk of cognitive decline compared with placebo

*Packaging may vary.

When a patient enters a significant caloric deficit, the body must catabolize (break down) stored energy

Risk of Amputation: There is an increased risk of lower limb amputation (toes, feet) associated with empagliflozin, particularly in patients with prior amputations, peripheral vascular disease, neuropathy, and diabetic foot ulcers

[9] [10] This dual action helps regulate blood glucose levels without causing hypoglycaemia when glucose concentrations are normal, though the risk of hypoglycaemia increases when used with insulin or sulfonylureas

The Importance of Glutathione Levels As we age, our natural levels of glutathione tend to decline